Dr. Lal Path Labs Ltd.
Dr. Lal PathLabs Limited is one of India‚Äôs leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are…
What Dr. files
- Others57
- Investor Meet32
- Updates25
- Important18
- Dividend/Bonus18
- Board Meeting14
DLPL announced its financial results for the quarter, kicking off FY27 with strong performance. Revenue reached ₹798 Cr, up 19.1% YoY, while Profit (PAT) surged 27.2% to ₹170 Cr. This growth was fueled by robust 10.7% sample volume and 8.2% patient volume increases, marking DLPL's highest quarterly revenue growth in...
Here's a concise, retail-friendly summary: **1. Business Performance:** Q3 FY26 revenue reached Rs. 660 Cr (+10.6% YoY), with 9M FY26 at Rs. 2,060 Cr (+10.8%). Q3 PAT was Rs. 91 Cr, impacted by a labor code charge; 9M PAT grew 12.2% to Rs. 378 Cr. Patient volumes rose 7.8% in...
Dr. Lal PathLabs reported robust performance with Q2 FY26 revenue at Rs. 731 crore, up 10.8% year-on-year. Half-year (H1 FY26) revenue reached Rs. 1400 crore, an 11.0% increase. Profit After Tax (PAT) showed strong growth, rising 16.4% in Q2 to Rs. 152 crore and 19.9% in H1 to Rs. 286...
1. **Financial Highlights:** Q1 FY26 saw revenue growth of 11.3% YoY to Rs. 670 Cr, driven by 10.7% sample volume increase. EBITDA jumped 13.1% to Rs. 192 Cr (28.7% margin), and PAT surged 24.3% to Rs. 134 Cr (20.0% margin). Strong cash flow supports self-funded growth. #LalPathLabs #Q1FY26 2. **Strategic...
**Q3 FY25 Performance Overview** Dr. Lal PathLabs has recorded a robust growth trajectory, with revenue reaching ₹597 crore in Q3 FY25, a year-on-year increase of 10.7%. Year-to-date revenue stands at ₹1,859 crore, growing 10.6% compared to the previous year. The operational efficiency has shown improvement, leading to an EBITDA of...